Foreign Military Sales restrictions
Foreign Military Sales restrictions carry direct compliance exposure for Healthcare & Life Sciences companies that supply dual-use medical equipment, biologics manufacturing technology, or diagnostic systems to defense-adjacent end users. The U.S. Department of State's Directorate of Defense Trade Controls enforces the International Traffic in Arms Regulations, and the U.S. Department of Commerce Bureau of Industry and Security separately controls export classification under the Export Administration Regulations, with both frameworks applying to life sciences goods that appear commercial on their face but meet military end-use definitions. Life sciences compliance teams are actively auditing distributor agreements and end-user certificates against ITAR Category XIV and EAR CCL categories before signing any government-adjacent supply contracts in flagged jurisdictions.
Watch
- ITAR Category XIV scope creep into medical countermeasure and biodefense product lines
- BIS Entity List additions in Asia-Pacific that include hospital networks and research institutions
- State Department policy on re-export of diagnostic imaging systems to FMS recipient countries
- Pending EAR rule on emerging biotechnology: proposed controls on fermentation and cell-culture equipment
- Third-party distributor vetting requirements under DDTC's 2023 brokering guidance
Recent material activity in Healthcare & Life Sciences
-
FDA issues Complete Response Letter for novel GLP-1 receptor agonist oral formulation
The FDA issued a CRL for a once-daily oral GLP-1 receptor agonist citing manufacturing consistency concerns at the primary production facility. The agency requested additional CMC data and a pre-approval inspection befor…
Read a full sample brief →